Interactive effect of STAT6 and IL13 gene polymorphisms on eczema status: Results from a longitudinal and a cross-sectional study

BMC Medical Genetics

Volumn 14, Issue 1, 2013, Pages

  Ziyab, Ali H ^a,b   Davies, Gwyneth A ^c   Ewart, Susan ^d   Hopkin, Julian M ^c   Schauberger, Eric M ^e   Wills Karp, Marsha ^f   Holloway, John W ^g   Arshad, Syed Hasan ^g,h   Zhang, Hongmei ^a   Karmaus, Wilfried ⁱ  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b KUWAIT UNIVERSITY   (Kuwait)

^c SWANSEA UNIVERSITY   (United Kingdom)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f The Johns Hopkins University   (United States)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h David Hide Asthma and Allergy Research Centre   (United Kingdom)

ⁱ UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Eczema; Epistasis; Gene gene Interaction; Genetic Association Study; IL13; STAT6

Indexed keywords

INTERLEUKIN 13; STAT6 PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECZEMA; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SALIVA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ECZEMA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-13; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STAT6 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 84879808085     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-14-67     Document Type: Article

References (45)

1. Bieber T. Atopic dermatitis. Ann Dermatol 2010, 22:125-137. 10.5021/ad.2010.22.2.125, 2883413, 20548901.
2. Sohn A, Frankel A, Patel RV, Goldenberg G. Eczema. Mt Sinai J Med 2011, 78:730-739. 10.1002/msj.20289, 21913202.
3. Emerson RM, Williams HC, Allen BR. What is the cost of atopic dermatitis in preschool children?. Br J Dermatol 2001, 144:514-522. 10.1046/j.1365-2133.2001.04077.x, 11260008.
4. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011, 242:233-246. 10.1111/j.1600-065X.2011.01027.x, 3122139, 21682749.
5. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009, 129:1892-1908. 10.1038/jid.2009.133, 19494826.
6. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008, 126:332-337. 10.1016/j.clim.2007.11.006, 2275206, 18166499.
7. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007, 120:150-155. 10.1016/j.jaci.2007.04.031, 2669594, 17512043.
8. Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, Redzic JS, Hansen KC, Leung DY. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008, 128:2248-2258. 10.1038/jid.2008.74, 18385759.
9. Bussmann C, Weidinger S, Novak N. Genetics of atopic dermatitis. J Dtsch Dermatol Ges 2011, 9:670-676.
10. He JQ, Chan-Yeung M, Becker AB, Dimich-Ward H, Ferguson AC, Manfreda J, Watson WT, Sandford AJ. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun 2003, 4:385-389. 10.1038/sj.gene.6363985, 12847555.
11. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, Duschl A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 2006, 17:173-188. 10.1016/j.cytogfr.2006.01.004, 16540365.
12. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003, 300:1527-1528. 10.1126/science.1085458, 12791978.
13. Goenka S, Kaplan MH. Transcriptional regulation by STAT6. Immunol Res 2011, 50:87-96. 10.1007/s12026-011-8205-2, 3107597, 21442426.
14. Henry J, Toulza E, Hsu CY, Pellerin L, Balica S, Mazereeuw-Hautier J, Paul C, Serre G, Jonca N, Simon M. Update on the epidermal differentiation complex. Front Biosci 2012, 17:1517-1532. 10.2741/4001, 22201818.
15. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998, 102:165-169. 10.1016/S0091-6749(98)70080-6, 9723655.
16. Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 2003, 111:677-690. quiz 691, 10.1067/mai.2003.1333, 12704343.
17. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005, 115:747-754. 548315, 15711639.
18. Andrews AL, Bucchieri F, Arima K, Izuhara K, Holgate ST, Davies DE, Holloway JW. Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110Q. J Allergy Clin Immunol 2007, 120:91-97. 10.1016/j.jaci.2007.04.026, 17560640.
19. Weidinger S, Klopp N, Wagenpfeil S, Rummler L, Schedel M, Kabesch M, Schafer T, Darsow U, Jakob T, Behrendt H, et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 2004, 41:658-663. 10.1136/jmg.2004.020263, 1735893, 15342695.
20. Gao PS, Heller NM, Walker W, Chen CH, Moller M, Plunkett B, Roberts MH, Schleimer RP, Hopkin JM, Huang SK. Variation in dinucleotide (GT) repeat sequence in the first exon of the STAT6 gene is associated with atopic asthma and differentially regulates the promoter activity in vitro. J Med Genet 2004, 41:535-539. 10.1136/jmg.2003.015842, 1447608,1447608, 15235025.
21. Tamura K, Suzuki M, Arakawa H, Tokuyama K, Morikawa A. Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int Arch Allergy Immunol 2003, 131:33-38. 10.1159/000070432, 12759487.
22. Granada M, Wilk JB, Tuzova M, Strachan DP, Weidinger S, Albrecht E, Gieger C, Heinrich J, Himes BE, Hunninghake GM, et al. A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study. J Allergy Clin Immunol 2012, 129:840-845. e821, 10.1016/j.jaci.2011.09.029, 3293994, 22075330.
23. Arshad SH, Karmaus W, Kurukulaaratchy R, Sadeghnejad A, Huebner M, Ewart S. Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood. Br J Dermatol 2008, 158:1315-1322. 10.1111/j.1365-2133.2008.08565.x, 2647137, 18410415.
24. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980, 92:44-47.
25. International HapMap C The International HapMap Project. Nature 2003, 426:789-796. 10.1038/nature02168, 14685227, International HapMap C.
26. Burney P, Chinn S. Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 1987, 91:79S-83S. 10.1378/chest.91.6_Supplement.79S, 3581967.
27. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 2008, 8:169-182. 10.1038/nri2257, 18301422.
28. Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med 2009, 163:438-445. 10.1001/archpediatrics.2009.31, 19414690.
29. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42:121-130. 10.2307/2531248, 3719049.
30. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995, 57:289-300.
31. Brown SJ, McLean WH. Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 2009, 129:543-552. 10.1038/jid.2008.413, 19209157.
32. Kiyohara C, Tanaka K, Miyake Y. Genetic susceptibility to atopic dermatitis. Allergol Int 2008, 57:39-56. 10.2332/allergolint.R-07-150, 18209506.
33. Ziyab AH, Raza A, Karmaus W, Tongue N, Zhang H, Matthews S, Arshad SH, Roberts G. Trends in eczema in the first 18 years of life: results from the Isle of Wight 1989 birth cohort study. Clin Exp Allergy 2010, 40:1776-1784. 10.1111/j.1365-2222.2010.03633.x, 21059120.
34. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 368:733-743. 10.1016/S0140-6736(06)69283-0, 16935684.
35. Osman M, Tagiyeva N, Wassall HJ, Ninan TK, Devenny AM, McNeill G, Helms PJ, Russell G. Changing trends in sex specific prevalence rates for childhood asthma, eczema, and hay fever. Pediatr Pulmonol 2007, 42:60-65. 10.1002/ppul.20545, 17133524.
36. Marinho S, Simpson A, Lowe L, Kissen P, Murray C, Custovic A. Rhinoconjunctivitis in 5-year-old children: a population-based birth cohort study. Allergy 2007, 62:385-393. 10.1111/j.1398-9995.2006.01294.x, 17362249.
37. Harrop J, Chinn S, Verlato G, Olivieri M, Norback D, Wjst M, Janson C, Zock JP, Leynaert B, Gislason D, et al. Eczema, atopy and allergen exposure in adults: a population-based study. Clin Exp Allergy 2007, 37:526-535. 10.1111/j.1365-2222.2007.02679.x, 17430349.
38. Weidinger S, Baurecht H, Naumann A, Novak N. Genome-wide association studies on IgE regulation: are genetics of IgE also genetics of atopic disease?. Curr Opin Allergy Clin Immunol 2010, 10:408-417. 10.1097/ACI.0b013e32833d7d2d, 20736732.
39. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009, 10:241-251.
40. Kraft P, Hunter DJ. Genetic risk prediction-are we there yet?. N Engl J Med 2009, 360:1701-1703. 10.1056/NEJMp0810107, 19369656.
41. Hong X, Tsai HJ, Liu X, Arguelles L, Kumar R, Wang G, Kuptsova-Clarkson N, Pearson C, Ortiz K, Bonzagni A, et al. Does genetic regulation of IgE begin in utero? Evidence from T(H)1/T(H)2 gene polymorphisms and cord blood total IgE. J Allergy Clin Immunol 2010, 126:1059-1067. 1067 e1051, 10.1016/j.jaci.2010.08.029, 3020083, 21050946.
42. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK, von Mutius E. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006, 117:269-274. 10.1016/j.jaci.2005.10.024, 16461126.
43. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003, 157:940-943. 10.1093/aje/kwg074, 12746247.
44. Ziyab AH, Karmaus W, Yousefi M, Ewart S, Schauberger E, Holloway JW, Zhang H, Arshad SH. Interplay of filaggrin loss-of-function variants, allergic sensitization, and eczema in a longitudinal study covering infancy to 18 years of age. PLoS One 2012, 7:e32721. 10.1371/journal.pone.0032721, 3293849, 22403702.
45. Brandt EB, Sivaprasad U. Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol 2011, 2(3):pii110.